Clinical trial
Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV…
NCT00038506 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00038506 |
|---|---|
| Title | Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure |
| Official title | A Phase IV, Open-label, Multicenter Study of Treatment With TRIZIVIR (Abacavir 300mg/Lamivudine 150mg/Zidovudine 300mg) Twice Daily and Tenofovir 300mg Once-daily for 48 Weeks in HIV-infected Subjects Experiencing Early Virologic Failure (ZIAGEN Intensification Protocol) |
| Lead sponsor | ViiV Healthcare, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | abacavir/lamivudine/zidovudine, tenofovir |
| Enrollment | 100 |
| Start date | Mar 1, 2002 |
| Primary completion | Aug 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Jun 3, 2002 |
| Last update posted | Apr 8, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: